S

Second Line

3 employees

Impact Investment Firm and Accelerator

Investor insights

Sectors invested in

PDC Cancer Therapeutics and Diagnostics1
Medical Device1
Early-Stage Chemotherapeutic Drug Conjugates1
Biotechnology1
Therapeutics1
Hematologic Malignancies1
Targeted Delivery of Oncologic Payloads1

Funding rounds participated in

$103M sweet spot round size

Most of their 1 investments are in rounds between $103M and $103M

Basic info

Industry

venture capital and private equity principals

Sectors

Design
Portfolio Management
Incubation
Narrative
Finance
Company Acceleration
Venture Capital
Impact Investing

Date founded

2011

Investments made

N

Novel Therapeutics Pvt Ltd. raised $103M on September 5, 2023

Investors: Second Line

FAQ